Disease Areas

News and analysis on disease research and diagnostics.

If recommended by the US Department of Health and Human Services, spinal muscular atrophy screening will potentially be adopted on the state level.

The new recommendation is a positive for Qiagen and Oxford Immunotec, both of which market interferon gamma-release assays.

The companies will work together to develop a series of cancer screening tests that employ Preora's cytology platform and its sample-preparation technologies.

Randox is using the funding, which includes £23 million from Invest NI, to create three centers in Northern Ireland to develop new diagnostic technologies.

A broad team of researchers has developed a microarray that looks for 171,000 different peptide fragments to differentiate among tick-borne diseases.